At the 2024 NextGen User Group Meeting #NextGenUGM24, the message was clear: The company continues to make steady improvements to its platform and remains focused on reducing administrative burden for both customers and partners….
Continue Reading
At the annual NextGen Healthcare User Group Meeting, the company did not make any flashy announcements or bold promises. Instead, they stayed true to the strategy set out a year ago – steady improvements…
Continue Reading
Full Disclosure: I’m not a doctor and I don’t play one on TV or this site. However, I am a patient that’s impacted by these options and so I’m writing from my informed patient…
Continue Reading
What You Should Know:
– H1, a provider of healthcare data and analytics, has announced significant enhancements to its Trial Landscape platform.
– These updates include the integration of diversity data for over 34 million patients…
Continue Reading
What You Should Know:
– Medable Inc., a provider of decentralized and hybrid clinical trial solutions, is collaborating with Google Cloud to make its Digital and Decentralized Clinical Trial Platform available on the Google Cloud…
Continue Reading
The following is a guest article by Bruno Kurtic, Co-Founder, President, and CEO at Bedrock Security
It’s becoming increasingly evident that the U.S. BIOSECURE Act will soon become the law of the land. The U.S….
The Associated Press reported recently that it has interviewed more than a dozen software engineers, developers and academic researchers who take issue with a claim by artificial intelligence developer OpenAI that one of its machine learning…
Continue Reading
What You Should Know:
– athenahealth, a prominent provider of network-enabled software for healthcare practices, has announced the limited release of *Ambient Notes*, an AI-driven tool integrated into the athenaOne platform, aiming to streamline clinical note…
Continue Reading
Oracle on Tuesday offered a sneak peek at its next-generation electronic health record which, more than two years since the company’s acquisition of Cerner, it says was rebuilt “from the ground up” to offer…
Continue Reading
What You Should Know:
– Innoventric, a leader in transcatheter tricuspid regurgitation (TR) treatment, today announced a $28.5 million Series B funding round to advance its revolutionary cross-caval technology, bringing the total funds raised since inception…
Continue Reading
